Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked to provide a scientific opinion on a list of health claims pursuant to Article 13 of Regulation (EC) No 1924/2006. This opinion addresses the scientific substantiation of health claims in relation to acacia gum (gum Arabic) and decreasing potentially pathogenic gastro-intestinal microorganisms, changes in short chain fatty acid (SCFA) production and pH in the gastro-intestinal tract, changes in bowel function, reduction of gastro-intestinal discomfort, maintenance of faecal nitrogen content and/or normal blood urea concentrations, and maintenance of normal blood LDL-cholesterol concentrations. The scientific substantiation is based on the information provided by the Member States in the consolidated list of Article 13 health claims and references that EFSA has received from Member States or directly from stakeholders. The food constituent that is the subject of the health claims is acacia gum (gum Arabic). The Panel considers that acacia gum is sufficiently characterised.
Scientific Opinion on the substantiation of health claims related to acacia gum (gum Arabic) and decreasing potentially pathogenic gastro-intestinal microorganisms (ID 758), changes in short chain fatty acid (SCFA) production and pH in the gastro-intestinal tract (ID 759), changes in bowel function (ID 759), reduction of gastro-intestinal discomfort (ID 759), maintenance of faecal nitrogen content and/or normal blood urea concentrations (ID 840, 1975), and maintenance of normal blood LDL-cholesterol concentrations (ID 841) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 / C.V. Agostoni, J.L. Bresson, S. Fairweather Tait, A. Flynn, I. Golly, H. Korhonen, P. Lagiou, M. Løvik, R. Marchelli, A. Martin, B. Moseley, M. Neuhäuser Berthold, H. Przyrembel, S. Salminen, Y. Sanz, S. Strain, S. Strobel, I. Tetens, D. Tomé, H. van Loveren, H. Verhagen. - In: EFSA JOURNAL. - ISSN 1831-4732. - 9:4(2011). [10.2903/j.efsa.2011.2022]
Scientific Opinion on the substantiation of health claims related to acacia gum (gum Arabic) and decreasing potentially pathogenic gastro-intestinal microorganisms (ID 758), changes in short chain fatty acid (SCFA) production and pH in the gastro-intestinal tract (ID 759), changes in bowel function (ID 759), reduction of gastro-intestinal discomfort (ID 759), maintenance of faecal nitrogen content and/or normal blood urea concentrations (ID 840, 1975), and maintenance of normal blood LDL-cholesterol concentrations (ID 841) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
C.V. AgostoniPrimo
;
2011
Abstract
Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked to provide a scientific opinion on a list of health claims pursuant to Article 13 of Regulation (EC) No 1924/2006. This opinion addresses the scientific substantiation of health claims in relation to acacia gum (gum Arabic) and decreasing potentially pathogenic gastro-intestinal microorganisms, changes in short chain fatty acid (SCFA) production and pH in the gastro-intestinal tract, changes in bowel function, reduction of gastro-intestinal discomfort, maintenance of faecal nitrogen content and/or normal blood urea concentrations, and maintenance of normal blood LDL-cholesterol concentrations. The scientific substantiation is based on the information provided by the Member States in the consolidated list of Article 13 health claims and references that EFSA has received from Member States or directly from stakeholders. The food constituent that is the subject of the health claims is acacia gum (gum Arabic). The Panel considers that acacia gum is sufficiently characterised.Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.